slide1
Better data for improved cancer diagnosis and prognosis
Learn how we do it
slide2
More objective data from a single tissue sample than ever before
Learn how we do it
slide3
The next generation of anatomic pathology and cancer diagnostics
Learn how we do it
Cernostics is focused on delivering the next generation of cancer diagnostics & prognostics through a unique approach to tissue analysis. Learn about our approach...

Barrett's Esophagus &
Esophageal Cancer

Three million people in the U.S. have Barrett’s Esophagus, a known precursor to esophageal cancer. Until now, identifying which patients are at greatest risk for esophageal cancer has been impossible. Cernostics is looking to change that… Learn how
News
View All News
12/3/2013
Cernostics Raises $1.4 Million in Series B Round... Read More
04/14/2013
Cernostics announces new scientific advisors... Read More
03/12/2012
Cernostics receives $55,000 investment from Ben Franklin Technology Partners... Read More
Events
10/18/2014 — Vienna, Austria
UEG Week (United European Gastroenterology Week)
06/23/2014 — San Diego, CA
BIO International Convention
05/03/2014 — Chicago, IL
DDW (Digestive Disease Week)
01/13/2014 — San Francisco, CA
JP Morgan Healthcare Conference
11/13/2013 — Philadelphia, PA
PA BIO Life Sciences Future Meeting